Science Current Events | Science News | Brightsurf.com
 

Target gene identified for therapies to combat muscular dystrophy

November 13, 2015

Researchers at the University of SĂ£o Paulo's Bioscience Institute (IB-USP) in Brazil have shown that a gene called Jagged1, or JAG1 for short, could be a target for the development of new approaches to treat Duchenne muscular dystrophy (DMD), a genetic disorder characterized by progressive muscle degeneration.

The research was carried out at the Human Genome & Stem Cell Research Center (HUG-CELL), one of the Research, Innovation and Dissemination Centers (RIDCs) supported by SĂ£o Paulo Research Foundation (FAPESP).

"All the genetic therapies tested so far, with little success, have targeted the gene that codes for the protein dystrophin. We're presenting a different approach, which opens up a range of new possibilities," said Mayana Zatz, Full Professor of Genetics at IB-USP and Head of HUG-CELL.

Duchenne muscular dystrophy, Zatz explained, primarily affects males and is the most common and most rapidly progressing type of muscular dystrophy. It is caused by a mutation, usually inherited, in the gene that encodes dystrophin, a protein that is essential for muscle health and is entirely absent in DMD patients.

"Dystrophin maintains the integrity of the membrane surrounding muscle cells," Zatz said. "When this protein is absent, the membrane becomes flaccid, so important proteins leak out of the muscle tissue and enter the bloodstream. Conversely, substances that should remain outside, such as calcium, are able to get in."

The heart, diaphragm and skeletal muscles are affected. Difficulty with walking and running first appear in boys aged between 3 and 5. Patients are usually confined to a wheelchair by age 10-12.

"Without special care, patients don't reach the age of 20. Nowadays, with assisted breathing, they may survive until they're 40 or beyond," Zatz said.

Over the past 15 years, researchers at HUG-CELL have performed experiments to extend our knowledge of DMD. They have studied animals such as Golden Retrievers born with a dystrophin gene mutation, which develop a clinical condition similar to human DMD. Most dystrophic dogs live for only two years or less.

"Some time ago, we identified a dog that totally lacked dystrophin yet presented with a much milder form of the disease," Zatz said. "It survived for 11 years, considered normal for this breed, and left a descendant that inherited the mutation and is now nine years old."

Ringo and Suflair, as the dogs were called, became the center of attention for the research group, that compared gene expression in healthy dogs, dogs with severe muscular dystrophy, and the above two dogs with the milder form of the disease.

The researchers found some candidate genes, and in a partnership with Professor Louis Kunkel and his team at Harvard Medical School, and Professor Kerstin Lindblad-Toh at the Broad Institute of MIT and Harvard in the United States, it was possible to combine the results with genetic data. They identified a region of the genome that's associated with the benign clinical condition and found increased expression of JAG1, a gene in this region, in Ringo and Suflair. This could explain why they have a more benign form of the disease

To confirm that alterations in JAG1 expression can indeed affect the severity of the disease, Vieira conducted experiments using a zebrafish model. The zebrafish (Danio rerio) shares approximately 70% of its genome with humans.

The experiments were performed in Prof. Kunkel's laboratory. Prof. Kunkel discovered the dystrophin gene and is currently a researcher at Harvard Medical School.

"The zebrafish model also has a dystrophin gene mutation," Zatz said. "As a result, its muscles are weak, and it can't move. When we increased JAG1 expression in zebrafish without dystrophin, we found that 75% failed to develop the dystrophic phenotype." Overexpression was induced in the model by injecting embryos with JAG1 messenger RNA.

FundaĂ§Ă£o de Amparo Ă  Pesquisa do Estado de SĂ£o Paulo


Related Dystrophin Current Events and Dystrophin News Articles


Stem cell gene therapy could be key to treating Duchenne muscular dystrophy
Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and Center for Duchenne Muscular Dystrophy at UCLA have developed a new approach that could eventually be used to treat Duchenne muscular dystrophy.

Gene-editing technique successfully stops progression of Duchenne muscular dystrophy
Using a new gene-editing technique, a team of scientists from UT Southwestern Medical Center stopped progression of Duchenne muscular dystrophy (DMD) in young mice.

Genetically correcting a muscle disorder
Three independent groups of researchers provide preliminary evidence that CRISPR can treat genetic disorders by editing a gene involved in muscle functioning, restoring some muscle function in mice with a specific type of muscular dystrophy.

Manipulating cell signaling for better muscle function in muscular dystrophy
Every heart beat and step in our daily lives is dependent on the integrity of muscles and the proteins that keep them strong and free of injury as they contract and relax.

Gene therapy treats all muscles in the body in muscular dystrophy dogs
Muscular dystrophy, which affects approximately 250,000 people in the U.S., occurs when damaged muscle tissue is replaced with fibrous, fatty or bony tissue and loses function.

New research sees zebrafish earn their stripes in the fight against muscular dystrophy
New research published today in the journal eLife has demonstrated a new method for observing the behaviour of the protein Dystrophin in a living animal cell, in real-time. This breakthrough may provide a key to understanding how to treat the genetic disease, Muscular Dystrophy.

Alternative strategy for gene replacement shows promise in duchenne muscular dystrophy
A gene therapy approach to treating the progressive muscle wasting disorder Duchenne muscular dystrophy (DMD) that does not replace the mutated DMD gene but instead delivers the gene for ITGA7, a protein in skeletal muscle, led to reduced symptoms and significantly extended life span in a mouse model of severe DMD.

Muscle fibers grown in the lab offer new model for studying muscular dystrophy
Skeletal muscle is one of the most abundant tissue types in the human body, but has proven difficult to produce in large quantities in the lab.

Cardiac stem cell therapy may heal heart damage caused by Duchenne muscular dystrophy
Researchers at the Cedars-Sinai Heart Institute have found that injections of cardiac stem cells might help reverse heart damage caused by Duchenne muscular dystrophy, potentially resulting in a longer life expectancy for patients with the chronic muscle-wasting disease.

Scientists pioneer microscopy technique that yields fresh data on muscular dystrophy
Scientists at USC have developed a new microscopy technology that allows them to view single molecules in living animals at higher-than-ever resolution.
More Dystrophin Current Events and Dystrophin News Articles

The dystrophin protein family: Localization and physiological role

The dystrophin protein family: Localization and physiological role
by Diana Hazai (Author)


Duchenne muscular dystrophy (DMD)is one of the most common, severe human disease. Mutations in the DMD gene are responsible for the disorder. Due to the mutations, dystrophin proteins are not expressed or expressed in functionally impaired form. The dystrophins are members of the dystrophin-associated protein complex (DAPC)located in the sarcolemma in the striated muscle. The DAPC links the extracellular matrix to the actin-based cytoskeleton and anchors signalling molecules. DAPC proteins are also localized in neurons and glia cells within the central nervous system and they interact with each other building up different types of DAPCs. Finding out the localization, colocalization of the DAPC proteins and the construction of the DAPC within the brain was the aim of the...

Structure and function of Native and edited dystrophin rods.

Structure and function of Native and edited dystrophin rods.
by Neha Sahni Ping Yu (Author)


Book by Sahni, Neha

Dystrophin: Gene, Protein and Cell Biology (French Edition)

Dystrophin: Gene, Protein and Cell Biology (French Edition)
by Susan C. Brown (Editor), Jack A. Lucy (Editor), Marlin Bobrow (Editor)


This book is concerned with advances in research on dystrophin, and how its absence gives rise to muscular dystrophy. It is the first book to address relationships between the molecular structure and function of dystrophin since the structure of the gene for this protein was elucidated in 1988. The volume covers recent advances in knowledge on the structure of both the dystrophin gene and its associated promoters, and on the protein itself. Functional interactions of dystrophin and its related proteins in the environment of the plasma membrane are a central feature of the book. Other aspects considered are the expression of the dystrophin complex in muscle, in the brain, and at the neuromuscular junction. The book concludes with discussions of muscle regeneration, gene therapy of Duchenne...

Dystrophin: Gene, Protein and Cell Biology (French Edition) (1997-05-13)

Dystrophin: Gene, Protein and Cell Biology (French Edition) (1997-05-13)
by Cambridge University Press (Publisher)




Dystrophin: Gene, Protein and Cell Biology (French Edition) (1997-05-13)

Dystrophin: Gene, Protein and Cell Biology (French Edition) (1997-05-13)
by Unknown (Author)




Biochemical Characterization of Dystrophin Spectrin Type Repeats: Biochemical and Biophysical analysis of Dystrophin Spectrin Type Repeats with emphasis on structure  prediction.

Biochemical Characterization of Dystrophin Spectrin Type Repeats: Biochemical and Biophysical analysis of Dystrophin Spectrin Type Repeats with emphasis on structure prediction.
by Ismaeel Muhamed (Author)


The dystrophin gene and its association with dystrophies is a prime factor to study the spectrin type repeats (STR) of dystrophin. There are 24 triple helical rods of Dystrophin STRs having four flexible hinges. The exon skipping and tissue specifity of the dystrophin isoforms make its function diverse. The deletion of STRs and mutations causes instability of the protein leading to diseases. This work studies the stability of spectrin type repeat, which would identify the roles and probably understand the function of individual spectrin repeat in diseases. The repeats are subjected to urea and temperature and the helical stability is measured. Structure prediction methods were worked on d1617 dystrophin spectrin double repeat to predict its structure which resulted in 4...

Muscle 2-Volume Set: Fundamental Biology and Mechanisms of Disease

Muscle 2-Volume Set: Fundamental Biology and Mechanisms of Disease
by Academic Press


A valuable study of the science behind the medicine, Muscle: Fundamental Biology and Mechanisms of Disease brings together key leaders in muscle biology. These experts provide state-of-the-art insights into the three forms of muscle--cardiac, skeletal, and smooth--from molecular anatomy, basic physiology, disease mechanisms, and targets of therapy. Commonalities and contrasts among these three tissue types are highlighted. This book focuses primarily on the biology of the myocyte. Individuals active in muscle investigation--as well as those new to the field--will find this work useful, as will students of muscle biology. In the case of hte former, many wish to grasp issues at the margins of their own expertise (e.g. clinical matters at one end; molecular matters at the other), adn this...

Neuromuscular Disorders: Management and Treatment E-Book

Neuromuscular Disorders: Management and Treatment E-Book
by Saunders


Neuromuscular Disorders presents a multi-disciplinary approach to the management and therapeutic treatment of the full range of neuromuscular disorders and resulting complications. Dr. Tulio Bertorini and a contributing team of the world’s leading authorities in the field provide the latest tools and strategies for minimizing disability and maximizing quality of life.Effectively treat your patients using the latest management tools and targeted therapeutic strategies. Manage all neuromuscular disorders as well as resulting complications through comprehensive coverage of diagnosis and evaluations, treatments, and outcomes. Apply the multi-disciplinary approach of an expert in clinical neuromuscular care and a team of world-renown contributors. Easily refer to tools for diagnosis,...

Muscle Biopsy E-Book: A Practical Approach

Muscle Biopsy E-Book: A Practical Approach
by Saunders


Muscle Biopsy: A Practical Approach gives you all of the unparalleled guidance necessary to effectively interpret and diagnose muscle biopsy specimens for the full range of diseases in both adults and children. Authored by Dr. Victor Dubowitz, an internationally renowned figure in the field of muscle disease, this medical reference book takes an integrated approach to diagnosis and assessment of muscle biopsies that includes clinical, genetic, biochemical, and pathological features. It's the comprehensive, up-to-date coverage you need to evaluate muscle disorders with confidence.Consult this title on your favorite e-reader, conduct rapid searches, and adjust font sizes for optimal readability.Bridge the gap between clinical syndromes/disorders and their underlying pathologies with the...

The Zebrafish: Disease Models and Chemical Screens, Volume 138, Fourth Edition (Methods in Cell Biology)

The Zebrafish: Disease Models and Chemical Screens, Volume 138, Fourth Edition (Methods in Cell Biology)
by H. William Detrich III (Editor), Leonard Zon (Editor), Monte Westerfield (Editor)


The Zebrafish: Disease Models and Chemical Screens, Fourth Edition, the latest volume in the Methods in Cell Biology series, looks at methods for analyzing genetics, genomics, and transcriptomics of zebrafish. Chapters cover such topics as gene-trap mutagenesis, genetic screens for mutations, gene editing in zebrafish, homologous gene targeting, genome-wide RNA tomography, developmental epigenetics, and the zebrafish interactome.
Covers sections on model systems and functional studies, imaging-based approaches, and emerging studiesIncludes chapters written by experts in the fieldContains cutting-edge material on the topics discussed

© 2017 BrightSurf.com